Please complete the CAPTCHA to continue
@cyrusbio.com
✓
3 phones found area 617
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mark Benjamin is listed as President & EVP Business Development at Cyrus Biotechnology at Cyrus Biotechnology, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at cyrusbio.com, phone signal with area code 617, and a matched LinkedIn profile for Mark Benjamin.
Mark Benjamin previously worked as President & EVP Business Development at Cyrus Biotechnology and Owner at Mbb Consulting Llc. Mark Benjamin holds D.Sc., Cancer Biology from Harvard University.
This section adds company-level context without repeating Mark Benjamin's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Benjamin. Compare company email patterns before reaching out.
INNOVATIVE BIOTECHNOLOGY EXECUTIVE DRIVING VISION AND DEVELOPING ORGANIZATIONS FOR BUSINESS GROWTH. A biotech industry executive leading strategic planning, business development, financing, and team development (both scientific and operational) that result in revenue-generating opportunities to maximize the value and success of innovative technology start-up companies. An influential and persuasive negotiator who effectively communicates the company's technology, value and direction to diverse stakeholders, resulting in strategic partnerships and high-value deals with customers, collaborators and investors. A transformational leader, I bring organizational structure, solid leadership that promotes a cooperative and creative culture, and process optimization expertise to rapidly evolving business environments.With a Harvard Doctorate of Science degree combined with a career that began in research, I developed a unique talent for translating and articulating complex science and technology into compelling business propositions understood by diverse audiences. In addition, my business experience has enabled me to develop keen cultural sensitivity/understanding critical to nurture relationships and bridge communications for conducting business and negotiating partnerships with European and Asian companies. Competitive Assets:♦ Corporate Strategy Planning♦ Business Development♦ Financing | Private Equity♦ Product / Asset Commercialization♦ P&L Management♦ External Communications♦ Value Creation♦ Organizational Development♦ International Business Negotiations♦ Contract Negotiations♦ Partnership / Collaboration Agreements♦ Performance Management♦ Team Building and Management
Listed skills include Business Development, Clinical Trials, Cancer, Lifesciences, and 21 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Seattle, Washington, US
Protein engineering and structure prediction, based on the Rosetta computational engine out of the UW lab of David Baker, directed at a new generation of protein therapeutics.
Consulting to the biotechnology industry with an emphasis on startup company and new initiatives development.Providing advice and mentoring to young companies, focused on strategic planning, business development, partnering, negotiations, fund-raising, communications, leadership and management.
Cambridge, MA, US
Lead business development operations, following Q-State's acquisition of Galenea. Helped refocus business development activities from multiple small technology-validating collaborations to high value partnerships, leading the negotiation of highly lucrative collaborations, including a multi-year drug discovery partnership with Vertex Pharmaceuticals..
Established the structure and a commercial vision for the discovery corporation, operating within a multi-year partnership with Otsuka Pharmaceuticals (OTSKZ: JP, Tokyo, Japan). Managed P&L and a 50+ employee organization in cutting-edge neuroscience R&D. Instituted a matrixed organizational structure for more efficient achievement of drug discovery.
Recruited to help rebuild Nura's organizational structure and promote viability of the commercial plan for the CNS therapeutics discovery company. As member of the operations management team, oversaw Operations and Human Resources. Involved in fundraising, establishing licensing agreements and developing revenue-generating collaborations. Secured access to.
Brought on board following the Swiss-based biotech company's formation to establish vision and strategy and to position DNA sequencing technology for the consumer market. Directed business development efforts in the US and Europe, including in-licensing of intellectual property, opportunity evaluation, service and research collaboration negotiation, and.
Seattle, Washington, US
Recruited by the company President to initiate, negotiate, and manage corporate alliances and create revenue-generating alliances in the pharmaceutical, biotechnology and agrigenomics industries. Built business development team, created commercialization plans for the technology, identified target companies, and developed relationships with lead.
Promoted to apply communications strengths in a dedicated business development role at the former pharmacogenomics company. Attended and presented research at industry conferences and collaborated with biotechnology companies to determine ways in which Xenometrix technologycould be applied to business strategy or product development. Raised several million.
Developed and executed communications strategy to showcase research value to the biotechnology community. Negotiated the company's partnerships and collaborations.
Managed a team of nine in multiple research programs in the company. Presented research topics and opportunities for collaboration to potential partners.Initially recruited as a Project Leader and Associate Laboratory Director (1992 - 1993) based on patent developed as a Postdoctoral Fellow at Harvard Medical School.
Quick answers generated from the profile data available on this page.
Mark Benjamin works for Cyrus Biotechnology.
Mark Benjamin is listed as President & EVP Business Development at Cyrus Biotechnology at Cyrus Biotechnology.
AeroLeads has found 1 work email signal at @cyrusbio.com for Mark Benjamin at Cyrus Biotechnology.
AeroLeads has found 3 phone signal(s) with area code 617 for Mark Benjamin at Cyrus Biotechnology.
Mark Benjamin is based in Cambridge, Massachusetts, United States while working with Cyrus Biotechnology.
Mark Benjamin has worked for Cyrus Biotechnology, Mbb Consulting Llc, Simcere Pharmaceutical Group, Phosphorex, and Q-State Biosciences.
You can use AeroLeads to view verified contact signals for Mark Benjamin at Cyrus Biotechnology, including work email, phone, and LinkedIn data when available.
Mark Benjamin holds D.Sc., Cancer Biology from Harvard University.
Mark Benjamin is listed with skills including Business Development, Clinical Trials, Cancer, Lifesciences, Biotechnology, Drug Discovery, Biochemistry, and Drug Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts